Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.